DRI-ecstasy plus mdma/MDA reagent

Ended Awarded

Contract number
N6854622F6084
Awardee
Awarding agency
Obligated
$6,421

Award facts

Contract value 100% obligated
$6,420.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Fremont, CA 94538, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of the Navy Bureau of Medicine and Surgery awarded a $6,420.80 firm fixed price delivery order contract to Microgenics Corporation for DRI-ECSTASY PLUS MDMA/MDA REAGENT. As the clinical diagnostics division of Thermo Electron Corporation, Microgenics will deliver the requested reagent to aid in drug testing and analysis at the place of performance in Fremont, California by the completion date of August 24, 2022. No set aside designation was used for this award to the prime contractor Microgenics to fulfill the Navy's Bureau of Medicine and Surgery's need for this diagnostic product under the terms specified.

Quick answers

Who was awarded contract N6854622F6084?

N6854622F6084 was awarded to Microgenics Corporation by Bureau of Medicine and Surgery (Department of the Navy) on August 17, 2022.

How much is contract N6854622F6084 worth?

The government has obligated $6,421 on N6854622F6084.

Is contract N6854622F6084 an order under another contract?

Yes. N6854622F6084 is a delivery order under N6264519D5003, an indefinite delivery contract.

Was contract N6854622F6084 competed?

The extent of competition for N6854622F6084 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award